EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1

NCT02844543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2018-05-30

Study results available
· View outcomes & findings →

Summary

This study will assess the effects of exercise and non-concussive bodily contact on eye-tracking scores collected by the EYE-SYNC eye-tracking device.

Conditions

  • Eye-tracking

Interventions

DEVICE

EYE-SYNC eye-tracking device

The EYE-SYNC® portable eye-tracking system. The eye tracker is a handheld isolated display environment with embedded eye tracking sensors. The eye tracker is connected to a high-performance Windows tablet though a customized docking station. Included accessories with EYE-SYNC are a U.S. tablet power supply adapter and disposable sanitary masks. Participants are asked to follow a dot with their eyes, as the dot moves on the screen of the EYE-SYNC device.

OTHER

SCAT-3

The Symptom subtest of SCAT-3 assessment tool will be administered to participants.

DEVICE

Desktop Eye-Tracker

Eye movements are recorded with an eye tracking system (Desktop Eye-Tracker, Eyelink CR, SR Research) with up to 1000 Hz temporal resolution. The target stimulus is presented on a computer screen approximately 50 cm from the participant. Participants are asked to follow a dot with their eyes, as the dot moves on the monitor screen of the desk-top eye-tracking device.

Sponsors & Collaborators

  • Brain Trauma Foundation

    collaborator OTHER
  • United States Department of Defense

    collaborator FED
  • Food and Drug Administration (FDA)

    collaborator FED
  • U.S. Army Medical Research and Development Command

    collaborator FED
  • Department of Health and Human Services

    collaborator FED
  • Stanford University

    lead OTHER

Principal Investigators

  • Jessica Little, PhD · Stanford University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844543 on ClinicalTrials.gov